# Pazopanib

NDC: 0480-4184
Generic name: Pazopanib
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20231020

FDA application: ANDA217517

## Active ingredients

- PAZOPANIB HYDROCHLORIDE: 200 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-4184"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-4184
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9f7ea520-a152-401e-b1f7-b5ef8c7a2239